ACTRN12605000520639
Completed
Phase 1
A Pharmacokinetic Phase I Study to Assess the Effect of Different Application Sites and Formulations, on the Relative Bioavailability and Pharmacokinetics of Estradiol in postmenopausal women from a Metered Dose Transdermal System (MDTS) as hormone replacement therapy.
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd0 sites12 target enrollmentSeptember 26, 2005
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Hormone replacement therapy in post-meonpausal women
- Sponsor
- FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A pharmacokinetic phase I study to assess the effect of different application sites on the pharmacokinetics of testosterone from a Testosterone Metered Dose (MD) Lotion in hypogonadism.HypogonadismMetabolic and Endocrine - DiabetesACTRN12605000518662Acrux DDS Pty Ltd12
Recruiting
Not Applicable
A phase I study to evaluate the pharmacokinetic interactions and safety between Amlodipine/Valsartan combination tablet and Rosuvastatin in healthy adult volunteersDiseases of the circulatory systemKCT0001660Kyung Dong Pharmaceutical57
Completed
Phase 1
A Phase 1 Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Selgantolimod upon Co-administration with a Representative Proton Pump Inhibitor or H2-Receptor AntagonistHepatitis BOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInfection - Other infectious diseasesACTRN12620001019998Gilead Sciences50
Completed
Phase 1
A Phase 1 Study of Olorofim in Healthy Japanese and Caucasian ParticipantsHealthy adult participantsJPRN-jRCT2031230016agata Tsutae24
Completed
Phase 1
A phase I study to assess the pharmacokinetics of a single dose of a slow-release solid injection of EPT1647 in healthy male volunteers/AHealthy male volunteersN/AOther -ACTRN12605000782639Epitan Limited6